Technology

Genea Biomedx and Gattaca Genomics Partner to Advance IVF Success Rates Through Groundbreaking Institutional Review Board Study

Published

7 hours ago

October 9, 2024

This collaboration supports a landmark IRB-approved study integrating Genea Biomedx’s cutting-edge time-lapse imaging technology with Gattaca Genomics’ genetic testing expertise.

FT. LAUDERDALE, Fla., Oct. 9, 2024 /PRNewswire-PRWeb/ — Genea Biomedx, a global leader in assisted reproductive technology (ART), and Gattaca Genomics, a trailblazer in reproductive health offering cutting-edge genetic testing to empower patients in their family planning journey, are excited to announce a new partnership aimed at advancing success rates for in vitro fertilization (IVF). This collaboration supports a landmark Institutional Review Board-approved study integrating Genea Biomedx’s cutting-edge time-lapse imaging technology with Gattaca Genomics’ genetic testing expertise. Together, the two companies will apply learned insight that will significantly improve embryo selection in IVF and enhance clinical outcomes for patients worldwide.

“This study could be a game-changer for couples struggling with infertility. By combining time-lapse imaging and genetic testing, we aim to provide experts with the insights to identify the most viable embryos, making IVF more successful.”

As part of the Agreement, Genea Biomedx will provide exclusively its state-of-the-art Geri® time-lapse incubators to select IVF clinics participating in the study. These incubators allow for continuous, real-time monitoring of embryo development, ensuring optimal culture conditions and gathering invaluable data. This innovative approach is designed to deepen the understanding of how embryo development correlates with aneuploidy—a genetic condition caused by an abnormal number of chromosomes that can impact embryo viability.

The study, titled “Embryo Assessment Utilizing Time-lapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next-Generation Sequencing,” will integrate Geri’s high-resolution imaging with Gattaca Genomics’ leading-edge genetic testing solutions. By combining their strengths, the companies aim to develop a comprehensive dataset that may redefine how healthy embryos are selected, potentially transforming IVF success rates and clinical outcomes.

Unlocking Clinical Potential in Clinics Globally

This partnership strengthens the scientific foundation of IVF treatments and highlights the substantial potential for Genea Biomedx and Gattaca Genomics. The collaboration opens new opportunities in the growing IVF market by uniting Genea Biomedx’s technological innovations with Gattaca Genomics’ genetic expertise. Around 100 IVF clinics globally will benefit from access to integrated solutions that can improve patient success rates and clinical efficiencies, further driving demand for Geri incubators and advanced genetic testing.

“This collaboration represents an exciting step forward in the science and business of IVF,” said Marian Garriga, CEO of Genea Biomedx. “By joining forces, we provide fertility specialists with the advanced tools they need while tapping into a substantial market with potential for exponential growth.”

Dr. Mari Mitrani, Chief Scientific Officer and co-founder at Gattaca Genomics, added: “This study could be a game-changer for couples struggling with infertility. By combining time-lapse imaging and genetic testing, we aim to provide experts with the insights to identify the most viable embryos, making IVF more successful.”

A Global Opportunity for IVF Clinics

Genea Biomedx and Gattaca Genomics are inviting leading IVF clinics worldwide to participate in this groundbreaking study. Clinics that join the study will gain access to Geri time-lapse incubators and advanced genetic testing, contributing to a global dataset that will redefine embryo selection standards.

“This collaborative effort unites leading IVF clinics worldwide in a shared mission to improve patient care and success rates,” said Dr. Tyl Taylor, Director of Genetic Services at Gattaca Genomics. “By providing the Geri incubator, Genea Biomedx is enabling us to collect high-quality data on embryo development and aneuploidy, helping us unlock valuable insights that will benefit countless families on their fertility journeys.”

For more details about the study design and participation, please visit ClinicalTrials.gov.

About Genea Biomedx

Genea Biomedx is a leading global provider and manufacturer of medical devices designed to simplify and automate the fertility treatment process, focusing on improving clinical outcomes. Genea Biomedx’s team of experts is dedicated to reducing the impact of uncontrollable variables like human error and environmental factors through innovative technology that enhances industry standards. Our cutting-edge devices provide exceptional performance and reliability, ensuring optimal clinical outcomes. Our products increase efficiency and reduce errors with intuitive interfaces and automated features. We invest heavily in R&D to help revolutionize the IVF industry. Genea Biomedx is a trusted partner that provides exceptional customer service, training, and technical support to laboratories worldwide.

About Gattaca Genomics

Gattaca Genomics is a trailblazer in reproductive health, offering cutting-edge genetic testing to empower patients in their family planning journey. Our expertise in Preimplantation Genetic Testing (PGT) and Whole Genome Sequencing (WGS) provides crucial insights to inform meaningful decisions. Led by CEO Michael Carbonara and Chief Scientific Officer Dr. Maria Ines “Mari” Mitrani, our team combines visionary leadership with scientific rigor to deliver personalized support and a deep understanding of each family’s unique needs. Gattaca Genomics is transforming family planning by harnessing the power of advanced technology, offering sophisticated solutions that enhance the chances of a healthy pregnancy while minimizing genetic risks.

Media Contact

Melany Velasquez, Gattaca Genomics, 1 888-372-8679, marley@dontbealittlepitch.com, www.gattacagenomics.com

View original content:https://www.prweb.com/releases/genea-biomedx-and-gattaca-genomics-partner-to-advance-ivf-success-rates-through-groundbreaking-institutional-review-board-study-302271820.html

SOURCE Gattaca Genomics

Technology

Toss Securities Announces Appointment of Gyubin Kim as New CEO

Published

52 mins ago

October 10, 2024

Gyubin Kim steps into new role as CEO of Toss SecuritiesPart of the strategy to strengthen the company’s investment platformDongwan Ko appointed as the new Head of Product… Strengthening product-centric operation

SEOUL, South Korea, Oct. 9, 2024 /PRNewswire/ — Toss Securities announced today that Gyubin Kim, the former Head of Product, has been appointed as the new CEO. The decision, made during a general shareholders’ meeting on the 10th, is part of a strategy to bolster Toss Securities’ standing as an investment platform and broaden its range of services.

Kim has been instrumental in driving service innovation since joining Toss Securities as a Product Owner (PO) in January 2022. His accomplishments include launching real-time fractional overseas stock trading and enhancing the investor community. Kim also contributed to the company’s first quarterly profit in 2023. He has laid the groundwork for Toss Securities services, such as launching overseas bonds, diversifying products, and introducing Toss Securities PC (Web Trading System).

Prior to joining Toss Securities, Kim honed his tech-based service planning skills at Toss (Viva Republica) and eBay Korea.

Following the recent executive appointments, Dongwan Ko, former PO, has assumed the position of the new Head of Product. Since joining Toss Securities, Ko has contributed in spearheading the company’s growth in overseas stock services.

Toss Securities, which began as an easy-to-use mobile stock trading service in March 2021, has grown into a brokerage firm with 6.3 million customers as of September 2024. The company has expanded its scope to cater not only to novice investors but also to professional investors. Focused on overseas stock brokerage services, Toss Securities turned a profit last year and is projected to continue its growth trajectory this year.

[Biography] Gyubin Kim, CEO of Toss Securities

Career Details:2022 – Present: Toss Securities2020 – 2022: Viva Republica2015 – 2020: eBay Korea2012 – 2013: Nanojo (Co-founder)Education: Graduated from Carnegie Mellon University / Electrical and Computer Engineering

About Toss Securities

Toss Securities, a subsidiary company of Viva Republica, which operates the financial super app Toss, launched its customer service in March 2021. As a newly licensed securities company after 13 years in South Korea, it provides user-centered services with UX/UI optimized for the mobile environment. In particular, it is the first in the industry to introduce an integrated account service that allows customers to conveniently trade multiple financial instruments from one account without installing a separate app, and as of September 2024, more than 6.3 million customers have used Toss Securities. Monthly Active Users (MAU) reach over 3.3 million to date. In addition to real-time overseas decimal stock trading, the company offers a variety of services such as community and customized content and is evolving into a data-driven investment platform.

View original content to download multimedia:https://www.prnewswire.com/news-releases/toss-securities-announces-appointment-of-gyubin-kim-as-new-ceo-302271574.html

SOURCE Toss Securities

Technology

Kehua Tech Ranked No. 1 in China and No. 3 Worldwide for Energy Storage Inverter Market Share

Published

52 mins ago

October 10, 2024

XIAMEN, China, Oct. 9, 2024 /PRNewswire/ — According to the report from S&P Global Commodity Insights, based on the 2023 PCS shipment volume statistics, Kehua is ranked as the No.3 energy storage inverter supplier globally and the No.1 energy storage supplier in China. Kehua‘s consistent growth and strong performance in the storage inverter market highlight the leading position in the industry.

Kehua’s rise to the top three global energy storage inverter suppliers is a reflection of the unwavering focus on meeting the evolving needs of customers and industry demands. Kehua’s ongoing technological innovations, especially breakthroughs in liquid cooling technology and grid-forming energy storage solutions, highlight its advanced capabilities and commitment to excellence. As Kehua continues to expand its presence in the global energy storage inverter market, it remains committed to driving innovation and setting new benchmarks for excellence.

In the future, Kehua will strengthen the cooperation with global partners to jointly promote the sustainable development of the energy industry and contribute to build a clean, efficient and sustainable energy ecosystem for the world.

About Kehua
Based on 36 years of experience in power electronic technology, Kehua has diversified solutions and rich project experience in the fields of photovoltaic, energy storage, micro-grids and integrated energy services. By the end of 2023, Kehua´s PV installation has exceeded 46GW and its energy storage installation has exceeded 15.2GW/8.2GWh globally. Presently, Kehua has become the world’s third largest PCS supplier (S&P), a Tier 1 energy storage supplier and a Top 10 solar inverter manufacturer (BloombergNEF). As a reliable PV and ESS expert, Kehua is dedicated to enabling a zero-carbon lifestyle for individuals worldwide.

View original content to download multimedia:https://www.prnewswire.com/news-releases/kehua-tech-ranked-no-1-in-china-and-no-3-worldwide-for-energy-storage-inverter-market-share-302272310.html

SOURCE Kehua Tech

Technology

HD Hyundai Heavy Industries Develops Eco-Friendly Ammonia Duel-fuel Engine

Published

52 mins ago

October 10, 2024

World’s first high-pressure ammonia direct injection engine receives model-based class approval from seven major classification societiesSuitable for marine power generation and propulsion, and land-based power generation, ready to be soonly commercialized for the market”We aim to enhance our advanced technology and take the lead in shipbuilding market”

SEOUL, South Korea, Oct. 9, 2024 /PRNewswire/ — HD Hyundai Heavy Industries aims to lead the eco-friendly shipbuilding market with the development of a zero-carbon ammonia dual-fuel (DF) engine. This is the first ammonia engine in the world, applied with a high-pressure ammonia direct injection method.

On October 7, HD Hyundai Heavy Industries announced that it had completed the model-based class approval testing for the “HiMSEN Ammonia Dual-Fuel Engine,” (model: H22CDF-LA) at its Engine Technology Center in the Ulsan Headquarters. The testing was attended by representatives from seven classification societies including ABS (USA), DNV (Norway), LR (UK), BV (France), RINA (Italy), NK (Japan), and KR (Korea).

HD Hyundai Heavy Industries shared that it will soon start commercialization of the HiMSEN ammonia engine as the detailed examination and compliance review has been finalized with the model-based class approval.

The ammonia engine developed by HD Hyundai Heavy Industries is suitable not only for ammonia carriers, but also for marine power generation and propulsion purposes. The company also plans to supply the engine to land-based power generation markets.

Until now, ammonia engines were based on a “low-pressure premixed combustion method” which burns a mixture of ammonia and air, which has been provided to the engine combustion chamber, through compression. The newly developed “high-pressure direct injection method” compresses air in the engine combustion chamber and then burns it by injecting ammonia with high pressure.

Despite its benefits of having great output and fuel efficiency, along with the mitigation of greenhouse gases such as nitrogen dioxide (N2O), engine companies around the world had difficulty developing this method due to its high technological complexity.

While setting up an optimized fuel spraying time and period to maximize burning rate, HD Hyundai Heavy Industries also utilized the selective catalytic reduction (SCR) system to minimize the amount of nitrogen oxide and unburned ammonia. In addition, the Integrated Scrubber developed independently by HD Korea Shipbuilding & Offshore Engineering, has been widely applied resulting in a drastic reduction of ammonia concentrations.

“The development of this ammonia engine has great meaning as it will be an opportunity for us to lead the market while providing an expanded eco-friendly duel-duel engine lineup,” said an official of HD Hyundai Heavy Industries. “We aim to enhance our advanced technology and take the lead in the future eco-friendly ship market.”

View original content to download multimedia:https://www.prnewswire.com/news-releases/hd-hyundai-heavy-industries-develops-eco-friendly-ammonia-duel-fuel-engine-302272313.html

SOURCE HD Hyundai